To include your compound in the COVID-19 Resource Center, submit it here.

Metadoxine ER: Phase IIb started

Alcobra began a double-blind, placebo-controlled Israeli Phase IIb trial to evaluate a single

Read the full 139 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE